Can You Trust CannTrust (TSX:TRST)?

CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) was recently busted for growing marijuana in unlicensed rooms. Is it still a good stock for your TFSA or RRSP?

question marks written reminders tickets

Image source: Getty Images

It is pretty ironic that a company named CannTrust (TSX:TRST)(NYSE:CTST) broke the trust of its investors. Health Canada suspended CannTrust’s licence to grow marijuana after reports that it illegally grew weed in unlicensed rooms.

This scandal lead to the firing of the CEO and many other senior management. At the end of the day, though, I am willing to forgive CannTrust for what the company has done.

It is no secret that governments are extremely bureaucratic. The process to get things done through a government agency is a job in itself! By operating the illegal grow rooms, CannTrust was able to accept much more business than it would have without them.

Given that Health Canada is a governmental organization, who knows how long it would have taken for the rooms to be licensed? By that time, the contracts could have been awarded to other companies.

While I absolve CannTrust of its guilt, it remains a poor investment due to the lack of ethics by senior management and tight cash reserves.

Lack of ethics

I know I’ve spent the first several paragraphs justifying the actions of CannTrust; however, at the end of the day, this scandal indicates that senior management seriously need ethics training.

I agree that senior management likely had the interest of investors in mind; however, with its current stock price, I can emphatically say that senior management has failed in that regard.

The issue with a scandal like this is it begets the question, “what else is the company hiding?”

An executive team with the audacity to dupe a government agency and the public certainly has other skeletons in its closet. The problem with this is investors never know if it is likely to benefit them down the road or harm them.

As an investor, I appreciate stability when investing in a company. Not in the sense of blue-chip, 100-year-old companies, but rather companies that don’t surprise you.

The reason for this is because no surprises are good surprises. Even if a company releases news that causes the share price to increase and investors to make double-digit returns, that is due to dumb luck. It very well could have gone the other way.

Thus, CannTrust and its unethical management team is not an investment that I would consider.

Tight cash reserves

Given that Health Canada has suspended its licence to grow any more weed, CannTrust needs to have massive cash reserves to maintain its current operations.

The company ended fiscal 2018 with $9 million in cash, which is not good. With operating expenses of $45 million in fiscal 2018 and current liabilities of $17 million, the company will be on the hook for $62 million of expense and liabilities in fiscal 2019, which cannot be met with current cash reserves.

Summary

CannTrust has dropped the ball in a big way. Senior management’s lack of ethics and the company’s tight cash reserves jeopardizes its ability to recover from this setback.

Unfortunately, a lack of ethics at the top permeates into the corporate culture, which means that even with the CEO and many senior management gone, it is very likely that the “cutting-corners” mentality will remain with the current employees.

This is definitely a stock to avoid.

If you liked this article, click the link below for exclusive insight.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chen Liu has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »